Related Experiment Video
Updated: Aug 15, 2026
08:58
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Biological effects of arginine metabolites
R C Blantz1, J Satriano, F Gabbai
1University of California, San Diego, California 92161, USA.
Acta Physiologica Scandinavica
|February 26, 2000
Summary
Arginine metabolites, nitric oxide (NO) and agmatine, regulate blood vessel dilation and kidney function. They also influence cell proliferation and interact within key metabolic pathways, highlighting their systemic importance.
Area of Science:
- Physiology
- Biochemistry
- Pharmacology
Background:
- Arginine and its metabolites, nitric oxide (NO) and agmatine, are crucial for vascular and kidney function.
- These compounds also play significant roles in regulating cell proliferation.
Purpose of the Study:
- To summarize the physiological effects of arginine metabolites, NO and agmatine.
- To explore the inter-regulation of arginine metabolic pathways.
Main Methods:
- Literature review of studies on arginine, NO, and agmatine.
- Analysis of their roles in vasodilation, glomerular filtration rate (GFR), and cell proliferation.
- Examination of interactions within nitric oxide synthase (NOS), arginase, ornithine decarboxylase (ODC), and arginine decarboxylase pathways.
Main Results:
- NO and agmatine promote vasodilation and increase GFR.
- Agmatine inhibits inducible nitric oxide synthase (iNOS).
- Both NO and agmatine affect polyamine synthesis and inhibit ornithine decarboxylase (ODC) through distinct mechanisms.
Conclusions:
- Arginine and its metabolites, NO and agmatine, are key regulators of vascular tone and kidney function.
- These metabolites significantly influence cell proliferation pathways.
- Complex inter-regulatory mechanisms exist among arginine metabolic pathways, including NOS, arginase, and decarboxylases.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...